ELDNHealthcareMicro-Cap
Eledon Pharmaceuticals, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Eledon Pharmaceuticals, Inc. (ELDN), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are ELDN insiders buying or selling?
Eledon Pharmaceuticals, Inc. insiders reported 12 open-market buys ($6.3M) and 5 sells ($2.3M) across 17 Form 4 filings — a net buying position of $4.0M.
Source: SEC EDGAR Form 4
Key Statistics (as of May 13, 2024)
Total Form 4 filings
17
SEC EDGAR
Insider filers
11
Insider buys (12)
$6.3M
Insider sells (5)
$2.3M
Insider sentiment
Net buyingNet insider flow of $4.0M in net buying.
Recent ELDN insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 13, 2024 | Mark N Lampert | 10% Owner | Purchase | 1.9M | $0.00 | $0 |
| May 10, 2023 | Mark N Lampert | 10% Owner | Purchase | 2.0M | $0.00 | $0 |
| Nov 23, 2022 | Steven Perrin | President | Purchase | 1.0K | $2.60 | $2.6K |
| Dec 21, 2021 | David-Alexandre C Gros | Chief Executive Officer | Purchase | 2.0K | $4.48 | $9.0K |
| Aug 19, 2021 | David-Alexandre C Gros | Chief Executive Officer | Purchase | 4.0K | $6.21 | $24.8K |
| Jun 14, 2021 | Paul Sean Little | CHIEF FINANCIAL OFFICER | Purchase | 10.0K | $8.87 | $88.7K |
| Jun 10, 2021 | David-Alexandre C Gros | Chief Executive Officer | Purchase | 3.0K | $8.01 | $24.0K |
| Dec 4, 2020 | OrbiMed Israel GP Ltd. | 10% Owner | Sale | 103.2K | $21.60 | $2.2M |
| Nov 6, 2020 | Logos Global Management LP | 10% Owner | Purchase | 79.1K | $25.25 | $2.0M |
| May 22, 2019 | Catherine C. Turkel | President | Sale | 9.5K | $1.95 | $18.6K |
| May 22, 2019 | Jon Kuwahara | Officer | Sale | 5.3K | $1.95 | $10.3K |
| May 22, 2019 | Gregory J. Flesher | Chief Executive Officer | Sale | 14.6K | $1.95 | $28.6K |
| May 6, 2019 | OrbiMed Israel GP Ltd. | Director, 10% Owner | Purchase | 646.2K | $3.10 | $2.0M |
| May 6, 2019 | Erez Chimovits | Director | Purchase | 646.2K | $3.10 | $2.0M |
| May 2, 2019 | LIFESCI INDEX PARTNERS LLC | 10% Owner | Sale | 200 | $2.70 | $540 |
| Sep 14, 2018 | Catherine C. Turkel | President | Purchase | 33.7K | $4.78 | $161.1K |
| Sep 8, 2018 | Catherine C. Turkel | President | Purchase | 805 | $3.97 | $3.2K |
Showing the 17 most recent of 17 Form 4 filings for Eledon Pharmaceuticals, Inc..
Most active ELDN insiders
- Catherine C. Turkel3 filings
- David-Alexandre C Gros3 filings
- OrbiMed Israel GP Ltd.2 filings
- Mark N Lampert2 filings
- Erez Chimovits1 filing
Ask anything about ELDN insider activity
Use Trabud's AI agent to query Eledon Pharmaceuticals, Inc.'s Form 4 history in plain English — "Show me ELDN CEO purchases this year" or compare it against any other ticker.
Open the AI agentELDN insider trading FAQ
Are Eledon Pharmaceuticals, Inc. insiders buying or selling?
Across 17 SEC Form 4 filings, Eledon Pharmaceuticals, Inc. (ELDN) insiders reported 12 open-market purchases totaling $6.3M and 5 sales totaling $2.3M. That is a net buying position of $4.0M.
How many insiders trade ELDN stock?
11 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Eledon Pharmaceuticals, Inc.. The most recent filing was accepted on May 13, 2024.
Where does Trabud get ELDN insider trading data?
All ELDN insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.